Key facts
- Tongxuan Medical’s last known valuation is $314.1M (Aug 2025).
- It has raised $41.8M; the latest was Early Stage VC ($41.8M) in Aug 2025.
- Notable investors include Qiming Venture Partners, Zhejiang Kunxin Investment Management, Hiway Capital, Minsheng Securities Investment, Nantong Blue Bay Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Tongxuan Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Tongxuan Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Tongxuan Medical
Developer and manufacturer of balloon dilatation catheters designed to serve the Chinese medical industry. The company offers prostatic dilatation catheters and other related catheter tubing products, thereby providing the urology medical industry with advanced catheter solutions.
- Sector
- Healthcare
- HQ
- Taizhou, China
- Founded
- 2020
- Website
- tongxuanyiliao.com/
- Ownership
- Privately Held (backing)
Tongxuan Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Tongxuan Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Tongxuan Medical in its N-PORT filings yet. We sweep new filings monthly.